ID   NCC-ASPS1-C1
AC   CVCL_ZZ81
DR   Wikidata; Q102114578
RX   PubMed=32648033;
WW   https://en.cellline.jp/product/ncc-asps1-c1/
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 6 days (PubMed=32648033).
CC   Sequence variation: Gene fusion; HGNC; 13825; ASPSCR1 + HGNC; 11752; TFE3; Name(s)=ASPSCR1-TFE3, ASPL-TFE3 (PubMed=32648033).
CC   Derived from site: In situ; Thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=32648033
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D21S11: 29
ST   D5S818: 10
ST   D7S820: 9,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3750; Alveolar soft part sarcoma
DI   ORDO; Orphanet_163699; Alveolar soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 7
//
RX   PubMed=32648033; DOI=10.1007/s13577-020-00382-2;
RA   Yoshimatsu Y., Noguchi R., Tsuchiya R., Sei A., Sugaya J.,
RA   Fukushima S., Yoshida A., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-ASPS1-C1: a novel
RT   patient-derived cell line of alveolar soft-part sarcoma.";
RL   Hum. Cell 33:1302-1310(2020).
//